Shopping Cart
- Remove All
- Your shopping cart is currently empty
U-46619 is an effective thromboxane A2 (TXA2) agonist and a thromboxane A2 analog (endoperoxide), capable of inducing contraction in the aortic smooth muscle (SM) of mice with a myosin light chain 9 (Myl9) gene deletion.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $243 | 35 days | |
5 mg | $1,090 | 35 days | |
10 mg | $1,820 | 35 days |
Description | U-46619 is an effective thromboxane A2 (TXA2) agonist and a thromboxane A2 analog (endoperoxide), capable of inducing contraction in the aortic smooth muscle (SM) of mice with a myosin light chain 9 (Myl9) gene deletion. |
In vitro | U-46619 (5 μg/kg; i.v.) significantly increased blood pressure in male spontaneously hypertensive rats.[3] The effect of Esmolol on blood pressure in male spontaneously hypertensive rats was shown in the study. [3] |
In vivo | U-46619 (5 μg/kg; i.v.) significantly increased blood pressure in male spontaneously hypertensive rats.[3] The effect of Esmolol on blood pressure in male spontaneously hypertensive rats was shown in the study. [3] |
Alias | 9,11-Methanoepoxy PGH2 |
Molecular Weight | 350.49 |
Formula | C21H34O4 |
Cas No. | 56985-40-1 |
Smiles | C(/C=C\CCCC(O)=O)[C@@H]1[C@@H](/C=C/[C@H](CCCCC)O)[C@]2(C[C@@]1(CO2)[H])[H] |
Relative Density. | 1.092g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.